Clinical Treatment for Covid-19 Market, Global Outlook and Forecast 2022-2028

February 2022 | 106 pages | ID: C7E787926DABEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Clinical Treatment for Covid-19 in Global, including the following market information:

Global Clinical Treatment for Covid-19 Market Size 2023-2028, ($ millions)

The global Clinical Treatment for Covid-19 market is projected to reach US$ million by 2028.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Treatment for Covid-19 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Treatment for Covid-19 Market, by Type, 2023-2028 ($ millions)

Global Clinical Treatment for Covid-19 Market Segment Percentages, by Type

• Antimicrobial Therapy
• Renal Failure and Renal Replacement Therapy
• Lung Replacement Therapy
• Immunotherapy
• Others

Global Clinical Treatment for Covid-19 Market, by Application, 2023-2028 ($ millions)

Global Clinical Treatment for Covid-19 Market Segment Percentages, by Application

• Children
• Adult
• Special Groups

Global Clinical Treatment for Covid-19 Market, By Region and Country, 2023-2028 ($ Millions)

Global Clinical Treatment for Covid-19 Market Segment Percentages, By Region and Country

• United States
• Europe
• Asia
• China
• Rest of World

Competitor Analysis

The report also provides analysis of leading market participants including:

Further, the report presents profiles of competitors in the market, key players include:

• Applied DNA Sciences, Inc
• Codagenix
• GeoVax Labs, Inc.
• Takis Biotech
• Evvivax
• Zydus Cadila
• MIGAL Galilee Research Institute
• Generex Biotechnology Corporation
• Moderna Therapeutics
• Novavax
• Bravovax
• Ascletis Pharma
• Janssen Pharmaceuticals
• Altimmune
• Greffex Inc.
• CanSino Biologics, Inc.
• ExpreS2ion Biotechnologies ApS
• Clover Biopharmaceuticals
• Vaxil Bio Ltd.
• iBio Pharma Inc
• Tonix Pharmaceuticals
• Curevac
• ImmunoPrecise

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clinical Treatment for Covid-19 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clinical Treatment for Covid-19 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLINICAL TREATMENT FOR COVID-19 OVERALL MARKET SIZE

2.1 Global Clinical Treatment for Covid-19 Market Size: 2022 VS 2028
2.2 Global Clinical Treatment for Covid-19 Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Key Clinical Treatment for Covid-19 Players in Global Market
3.2 Global Companies Clinical Treatment for Covid-19 Product & Technology

4 PLAYERS PROFILES

4.1 Applied DNA Sciences, Inc
  4.1.1 Applied DNA Sciences, Inc Corporate Summary
  4.1.2 Applied DNA Sciences, Inc Business Overview
  4.1.3 Applied DNA Sciences, Inc Clinical Treatment for Covid-19 Product Offerings & Technology
  4.1.4 Applied DNA Sciences, Inc Clinical Treatment for Covid-19 R&D, and Plans
4.2 Codagenix
  4.2.1 Codagenix Corporate Summary
  4.2.2 Codagenix Business Overview
  4.2.3 Codagenix Clinical Treatment for Covid-19 Product Offerings & Technology
  4.2.4 Codagenix Clinical Treatment for Covid-19 R&D, and Plans
4.3 GeoVax Labs, Inc.
  4.3.1 GeoVax Labs, Inc. Corporate Summary
  4.3.2 GeoVax Labs, Inc. Business Overview
  4.3.3 GeoVax Labs, Inc. Clinical Treatment for Covid-19 Product Offerings & Technology
  4.3.4 GeoVax Labs, Inc. Clinical Treatment for Covid-19 R&D, and Plans
4.4 Takis Biotech
  4.4.1 Takis Biotech Corporate Summary
  4.4.2 Takis Biotech Business Overview
  4.4.3 Takis Biotech Clinical Treatment for Covid-19 Product Offerings & Technology
  4.4.4 Takis Biotech Clinical Treatment for Covid-19 R&D, and Plans
4.5 Evvivax
  4.5.1 Evvivax Corporate Summary
  4.5.2 Evvivax Business Overview
  4.5.3 Evvivax Clinical Treatment for Covid-19 Product Offerings & Technology
  4.5.4 Evvivax Clinical Treatment for Covid-19 R&D, and Plans
4.6 Zydus Cadila
  4.6.1 Zydus Cadila Corporate Summary
  4.6.2 Zydus Cadila Business Overview
  4.6.3 Zydus Cadila Clinical Treatment for Covid-19 Product Offerings & Technology
  4.6.4 Zydus Cadila Clinical Treatment for Covid-19 R&D, and Plans
4.7 MIGAL Galilee Research Institute
  4.7.1 MIGAL Galilee Research Institute Corporate Summary
  4.7.2 MIGAL Galilee Research Institute Business Overview
  4.7.3 MIGAL Galilee Research Institute Clinical Treatment for Covid-19 Product Offerings & Technology
  4.7.4 MIGAL Galilee Research Institute Clinical Treatment for Covid-19 R&D, and Plans
4.8 Generex Biotechnology Corporation
  4.8.1 Generex Biotechnology Corporation Corporate Summary
  4.8.2 Generex Biotechnology Corporation Business Overview
  4.8.3 Generex Biotechnology Corporation Clinical Treatment for Covid-19 Product Offerings & Technology
  4.8.4 Generex Biotechnology Corporation Clinical Treatment for Covid-19 R&D, and Plans
4.9 Moderna Therapeutics
  4.9.1 Moderna Therapeutics Corporate Summary
  4.9.2 Moderna Therapeutics Business Overview
  4.9.3 Moderna Therapeutics Clinical Treatment for Covid-19 Product Offerings & Technology
  4.9.4 Moderna Therapeutics Clinical Treatment for Covid-19 R&D, and Plans
4.10 Novavax
  4.10.1 Novavax Corporate Summary
  4.10.2 Novavax Business Overview
  4.10.3 Novavax Clinical Treatment for Covid-19 Product Offerings & Technology
  4.10.4 Novavax Clinical Treatment for Covid-19 R&D, and Plans
4.11 Bravovax
  4.11.1 Bravovax Corporate Summary
  4.11.2 Bravovax Business Overview
  4.11.3 Bravovax Clinical Treatment for Covid-19 Product Offerings & Technology
  4.11.4 Bravovax Clinical Treatment for Covid-19 R&D, and Plans
4.12 Ascletis Pharma
  4.12.1 Ascletis Pharma Corporate Summary
  4.12.2 Ascletis Pharma Business Overview
  4.12.3 Ascletis Pharma Clinical Treatment for Covid-19 Product Offerings & Technology
  4.12.4 Ascletis Pharma Clinical Treatment for Covid-19 R&D, and Plans
4.13 Janssen Pharmaceuticals
  4.13.1 Janssen Pharmaceuticals Corporate Summary
  4.13.2 Janssen Pharmaceuticals Business Overview
  4.13.3 Janssen Pharmaceuticals Clinical Treatment for Covid-19 Product Offerings & Technology
  4.13.4 Janssen Pharmaceuticals Clinical Treatment for Covid-19 R&D, and Plans
4.14 Altimmune
  4.14.1 Altimmune Corporate Summary
  4.14.2 Altimmune Business Overview
  4.14.3 Altimmune Clinical Treatment for Covid-19 Product Offerings & Technology
  4.14.4 Altimmune Clinical Treatment for Covid-19 R&D, and Plans
4.15 Greffex Inc.
  4.15.1 Greffex Inc. Corporate Summary
  4.15.2 Greffex Inc. Business Overview
  4.15.3 Greffex Inc. Clinical Treatment for Covid-19 Product Offerings & Technology
  4.15.4 Greffex Inc. Clinical Treatment for Covid-19 R&D, and Plans
4.16 CanSino Biologics, Inc.
  4.16.1 CanSino Biologics, Inc. Corporate Summary
  4.16.2 CanSino Biologics, Inc. Business Overview
  4.16.3 CanSino Biologics, Inc. Clinical Treatment for Covid-19 Product Offerings & Technology
  4.16.4 CanSino Biologics, Inc. Clinical Treatment for Covid-19 R&D, and Plans
4.17 ExpreS2ion Biotechnologies ApS
  4.17.1 ExpreS2ion Biotechnologies ApS Corporate Summary
  4.17.2 ExpreS2ion Biotechnologies ApS Business Overview
  4.17.3 ExpreS2ion Biotechnologies ApS Clinical Treatment for Covid-19 Product Offerings & Technology
  4.17.4 ExpreS2ion Biotechnologies ApS Clinical Treatment for Covid-19 R&D, and Plans
4.18 Clover Biopharmaceuticals
  4.18.1 Clover Biopharmaceuticals Corporate Summary
  4.18.2 Clover Biopharmaceuticals Business Overview
  4.18.3 Clover Biopharmaceuticals Clinical Treatment for Covid-19 Product Offerings & Technology
  4.18.4 Clover Biopharmaceuticals Clinical Treatment for Covid-19 R&D, and Plans
4.19 Vaxil Bio Ltd.
  4.19.1 Vaxil Bio Ltd. Corporate Summary
  4.19.2 Vaxil Bio Ltd. Business Overview
  4.19.3 Vaxil Bio Ltd. Clinical Treatment for Covid-19 Product Offerings & Technology
  4.19.4 Vaxil Bio Ltd. Clinical Treatment for Covid-19 R&D, and Plans
4.20 iBio Pharma Inc
  4.20.1 iBio Pharma Inc Corporate Summary
  4.20.2 iBio Pharma Inc Business Overview
  4.20.3 iBio Pharma Inc Clinical Treatment for Covid-19 Product Offerings & Technology
  4.20.4 iBio Pharma Inc Clinical Treatment for Covid-19 R&D, and Plans
4.21 Tonix Pharmaceuticals
  4.21.1 Tonix Pharmaceuticals Corporate Summary
  4.21.2 Tonix Pharmaceuticals Business Overview
  4.21.3 Tonix Pharmaceuticals Clinical Treatment for Covid-19 Product Offerings & Technology
  4.21.4 Tonix Pharmaceuticals Clinical Treatment for Covid-19 R&D, and Plans
4.22 Curevac
  4.22.1 Curevac Corporate Summary
  4.22.2 Curevac Business Overview
  4.22.3 Curevac Clinical Treatment for Covid-19 Product Offerings & Technology
  4.22.4 Curevac Clinical Treatment for Covid-19 R&D, and Plans
4.23 ImmunoPrecise
  4.23.1 ImmunoPrecise Corporate Summary
  4.23.2 ImmunoPrecise Business Overview
  4.23.3 ImmunoPrecise Clinical Treatment for Covid-19 Product Offerings & Technology
  4.23.4 ImmunoPrecise Clinical Treatment for Covid-19 R&D, and Plans

5 SIGHTS BY REGION

5.1 By Region - Global Clinical Treatment for Covid-19 Market Size, 2023 & 2028
5.2 By Region - Global Clinical Treatment for Covid-19 Revenue, (2023-2028)
5.3 United States
  5.3.1 Key Players of Clinical Treatment for Covid-19 in United States
  5.3.2 United States Clinical Treatment for Covid-19 Development Current Situation and Forecast
5.4 Europe
  5.4.1 Key Players of Clinical Treatment for Covid-19 in Europe
  5.4.2 Europe Clinical Treatment for Covid-19 Development Current Situation and Forecast
5.5 China
  5.5.1 Key Players of Clinical Treatment for Covid-19 in China
  5.5.2 China Clinical Treatment for Covid-19 Development Current Situation and Forecast
5.6 Rest of World

6 SIGHTS BY PRODUCT

6.1 by Type - Global Clinical Treatment for Covid-19 Market Size Markets, 2023 & 2028
6.2 Antimicrobial Therapy
6.3 Renal Failure and Renal Replacement Therapy
6.4 Lung Replacement Therapy
6.5 Immunotherapy
6.6 Others

7 SIGHTS BY APPLICATION

7.1 By Application - Global Clinical Treatment for Covid-19 Market Size, 2023 & 2028
7.2 Children
7.3 Adult
7.4 Special Groups

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Clinical Treatment for Covid-19 Market Opportunities & Trends in Global Market
Table 2. Clinical Treatment for Covid-19 Market Drivers in Global Market
Table 3. Clinical Treatment for Covid-19 Market Restraints in Global Market
Table 4. Key Players of Clinical Treatment for Covid-19 in Global Market
Table 5. Global Companies Clinical Treatment for Covid-19 Product & Technology
Table 6. Applied DNA Sciences, Inc Corporate Summary
Table 7. Applied DNA Sciences, Inc Clinical Treatment for Covid-19 Product Offerings
Table 8. Codagenix Corporate Summary
Table 9. Codagenix Clinical Treatment for Covid-19 Product Offerings
Table 10. GeoVax Labs, Inc. Corporate Summary
Table 11. GeoVax Labs, Inc. Clinical Treatment for Covid-19 Product Offerings
Table 12. Takis Biotech Corporate Summary
Table 13. Takis Biotech Clinical Treatment for Covid-19 Product Offerings
Table 14. Evvivax Corporate Summary
Table 15. Evvivax Clinical Treatment for Covid-19 Product Offerings
Table 16. Zydus Cadila Corporate Summary
Table 17. Zydus Cadila Clinical Treatment for Covid-19 Product Offerings
Table 18. MIGAL Galilee Research Institute Corporate Summary
Table 19. MIGAL Galilee Research Institute Clinical Treatment for Covid-19 Product Offerings
Table 20. Generex Biotechnology Corporation Corporate Summary
Table 21. Generex Biotechnology Corporation Clinical Treatment for Covid-19 Product Offerings
Table 22. Moderna Therapeutics Corporate Summary
Table 23. Moderna Therapeutics Clinical Treatment for Covid-19 Product Offerings
Table 24. Novavax Corporate Summary
Table 25. Novavax Clinical Treatment for Covid-19 Product Offerings
Table 26. Bravovax Corporate Summary
Table 27. Bravovax Clinical Treatment for Covid-19 Product Offerings
Table 28. Ascletis Pharma Corporate Summary
Table 29. Ascletis Pharma Clinical Treatment for Covid-19 Product Offerings
Table 30. Janssen Pharmaceuticals Corporate Summary
Table 31. Janssen Pharmaceuticals Clinical Treatment for Covid-19 Product Offerings
Table 32. Altimmune Corporate Summary
Table 33. Altimmune Clinical Treatment for Covid-19 Product Offerings
Table 34. Greffex Inc. Corporate Summary
Table 35. Greffex Inc. Clinical Treatment for Covid-19 Product Offerings
Table 36. CanSino Biologics, Inc. Corporate Summary
Table 37. CanSino Biologics, Inc. Clinical Treatment for Covid-19 Product Offerings
Table 38. ExpreS2ion Biotechnologies ApS Corporate Summary
Table 39. ExpreS2ion Biotechnologies ApS Clinical Treatment for Covid-19 Product Offerings
Table 40. Clover Biopharmaceuticals Corporate Summary
Table 41. Clover Biopharmaceuticals Clinical Treatment for Covid-19 Product Offerings
Table 42. Vaxil Bio Ltd. Corporate Summary
Table 43. Vaxil Bio Ltd. Clinical Treatment for Covid-19 Product Offerings
Table 44. iBio Pharma Inc Corporate Summary
Table 45. iBio Pharma Inc Clinical Treatment for Covid-19 Product Offerings
Table 46. Tonix Pharmaceuticals Corporate Summary
Table 47. Tonix Pharmaceuticals Clinical Treatment for Covid-19 Product Offerings
Table 48. Curevac Corporate Summary
Table 49. Curevac Clinical Treatment for Covid-19 Product Offerings
Table 50. ImmunoPrecise Corporate Summary
Table 51. ImmunoPrecise Clinical Treatment for Covid-19 Product Offerings
Table 52. By Region– Global Clinical Treatment for Covid-19 Revenue, (US$, Mn), 2023 & 2028
Table 53. By Region - Global Clinical Treatment for Covid-19 Revenue, (US$, Mn), 2023-2028
Table 54. By Type – Global Clinical Treatment for Covid-19 Market Size, (US$, Mn), 2023 & 2028
Table 55. By Application– Global Clinical Treatment for Covid-19 Market Size, (US$, Mn), 2023 & 2028

List Of Figures

LIST OF FIGURES

Figure 1. Clinical Treatment for Covid-19 Segment by Type in 2021
Figure 2. Clinical Treatment for Covid-19 Segment by Application in 2021
Figure 3. Global Clinical Treatment for Covid-19 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Clinical Treatment for Covid-19 Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global Clinical Treatment for Covid-19 Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Clinical Treatment for Covid-19 Revenue Market Share, 2023-2028
Figure 8. By Type - Global Clinical Treatment for Covid-19 Revenue Market Share, 2023-2028
Figure 9. By Application - Global Clinical Treatment for Covid-19 Revenue Market Share, 2023-2028